对不同针方法与抗抑郁药物结合进行的元分析,以减少严重抑郁症
1Psychiatry and Psychology Department, Xi'an Third Hospital, Xi'an, China.
Clinical neuropharmacology
|August 14, 2024
概括
针,特别是手动针,可能有助于减少主要抑郁症 (MDD) 症状严重程度,特别是与抗抑郁药物结合使用时. 然而,确的临床益处需要进一步研究.
科学领域:
- 综合医学是一个整体的医学.
- 精神病学是一个精神病学.
- 临床研究 临床研究
背景情况:
- 针作为抑郁症的治疗方法正在被探索.
- 在重大抑郁障碍 (MDD) 中针的临床证据受到争议.
研究的目的:
- 系统地评估针治疗重大抑郁症 (MDD) 的疗效.
- 评估不同针方式和同时使用抗抑郁药对MDD症状严重性的影响.
主要方法:
- 在2023年11月之前发表的9项随机临床试验 (809名受试者) 的元分析.
- 包括的研究使用预后研究质量 (QUIPS) 工具进行了质量评估.
- 分析了与MDD严重程度相关的结果,考虑了手动针,激光针,电针和抗抑郁药的使用.
主要成果:
- 针在缓解MDD严重程度方面显示出适度的,尽管在统计学上没有显著的影响 (SMD = -0.55).
- 手动针,特别是当与抗抑郁药一起使用时,证明了MDD严重程度的显著减少 (SMD = -0.47).
- 激光针和电针并没有显著改善MDD的严重程度.
结论:
- 手动针,有或没有抗抑郁药物,可能为MDD症状严重程度提供一些缓解.
- 针治疗MDD的整体临床益处仍然没有确定性,需要进一步进行高质量的研究.
更多相关视频
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.5K
07:29Author Spotlight: Development of a Standardized Acupuncture Tool Inspired by Advanced Techniques for Improved Safety and Precision
Published on: January 10, 2025
281
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
339
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
339